|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
1 | AN ACT concerning criminal law.
| ||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||
4 | Section 5. The Illinois Controlled Substances Act is | ||||||||||||||||||||||||
5 | amended by changing Sections 313 and 406 and adding Section | ||||||||||||||||||||||||
6 | 316.5 as follows:
| ||||||||||||||||||||||||
7 | (720 ILCS 570/313) (from Ch. 56 1/2, par. 1313)
| ||||||||||||||||||||||||
8 | Sec. 313. (a) Controlled substances which are lawfully | ||||||||||||||||||||||||
9 | administered in
hospitals or institutions licensed under the | ||||||||||||||||||||||||
10 | "Hospital Licensing Act" shall
be exempt from the requirements | ||||||||||||||||||||||||
11 | of Sections 312 and 316 except
that the
prescription for the | ||||||||||||||||||||||||
12 | controlled substance shall be in writing on the
patient's | ||||||||||||||||||||||||
13 | record, signed by the prescriber, dated, and shall state the
| ||||||||||||||||||||||||
14 | name, and quantity of controlled substances ordered and the | ||||||||||||||||||||||||
15 | quantity
actually administered. The records of such | ||||||||||||||||||||||||
16 | prescriptions shall be
maintained for two years and shall be | ||||||||||||||||||||||||
17 | available for inspection by officers
and employees of the | ||||||||||||||||||||||||
18 | Department of State Police, and the Department of
Professional | ||||||||||||||||||||||||
19 | Regulation.
| ||||||||||||||||||||||||
20 | (b) Controlled substances that can lawfully be | ||||||||||||||||||||||||
21 | administered or dispensed
directly to a patient in a long-term | ||||||||||||||||||||||||
22 | care facility licensed by the Department
of Public Health as a | ||||||||||||||||||||||||
23 | skilled nursing facility, intermediate care facility, or
|
| |||||||
| |||||||
1 | long-term care facility for residents under 22 years of age, | ||||||
2 | are exempt from
the requirements of Section 312 except that a | ||||||
3 | prescription
for a
Schedule II controlled substance must be | ||||||
4 | either a written prescription signed
by the prescriber or a | ||||||
5 | written prescription transmitted by the prescriber or
| ||||||
6 | prescriber's agent to the dispensing pharmacy by facsimile. The
| ||||||
7 | facsimile serves as the original prescription and must be | ||||||
8 | maintained for 2
years from the date of issue in the same | ||||||
9 | manner as a written prescription
signed by the prescriber.
| ||||||
10 | (c) A prescription that is written for a Schedule II | ||||||
11 | controlled substance
to be compounded for direct | ||||||
12 | administration by parenteral, intravenous,
intramuscular, | ||||||
13 | subcutaneous, or intraspinal infusion to a patient in a private
| ||||||
14 | residence, long-term care facility, or hospice setting may be | ||||||
15 | transmitted by
facsimile by the prescriber or the prescriber's | ||||||
16 | agent to the pharmacy providing
the home infusion services. The | ||||||
17 | facsimile serves as the original written
prescription for | ||||||
18 | purposes of this paragraph (c) and it shall be maintained in
| ||||||
19 | the same manner as the original written prescription.
| ||||||
20 | (c-1) A prescription written for a Schedule II controlled | ||||||
21 | substance for a
patient residing in a hospice certified by | ||||||
22 | Medicare under Title XVIII of the
Social Security Act or
| ||||||
23 | licensed by the State may be transmitted by the practitioner or | ||||||
24 | the
practitioner's
agent to the dispensing pharmacy by | ||||||
25 | facsimile. The practitioner or
practitioner's
agent must note | ||||||
26 | on the prescription that the patient is a hospice patient. The
|
| |||||||
| |||||||
1 | facsimile serves as the original written prescription for | ||||||
2 | purposes of this
paragraph (c-1) and it shall be maintained in | ||||||
3 | the same manner as the original
written prescription.
| ||||||
4 | (d) Controlled substances which are lawfully administered
| ||||||
5 | and/or dispensed
in drug abuse treatment programs licensed by | ||||||
6 | the Department shall be exempt
from the requirements of | ||||||
7 | Sections 312 and 316.5
316 , except that the
prescription
for | ||||||
8 | such controlled substances shall be issued and authenticated
on | ||||||
9 | official prescription logs prepared and supplied by the | ||||||
10 | Department.
The official prescription logs issued by the | ||||||
11 | Department shall be printed
in triplicate on distinctively | ||||||
12 | marked paper and furnished to programs at
reasonable cost. The | ||||||
13 | official prescription logs furnished to the programs
shall | ||||||
14 | contain, in preprinted form, such information as the Department | ||||||
15 | may
require. The official prescription logs shall be properly | ||||||
16 | endorsed by a
physician licensed to practice medicine in all | ||||||
17 | its branches issuing the
order, with his own signature and the | ||||||
18 | date of
ordering, and further endorsed by the practitioner | ||||||
19 | actually administering
or dispensing the dosage at the time of | ||||||
20 | such administering or dispensing in
accordance with | ||||||
21 | requirements issued by the Department. The duplicate copy
shall | ||||||
22 | be retained by the program for a period of not less than three | ||||||
23 | years
nor more than seven years; the original and triplicate | ||||||
24 | copy shall be
returned to the Department at its principal | ||||||
25 | office in accordance with
requirements set forth by the | ||||||
26 | Department.
|
| |||||||
| |||||||
1 | (Source: P.A. 91-576, eff. 4-1-00; 91-714, eff. 6-2-00.)
| ||||||
2 | (720 ILCS 570/316.5 new) | ||||||
3 | Sec. 316.5. Electronic system for monitoring controlled | ||||||
4 | substances.
| ||||||
5 | (a) The Department shall establish an electronic system for
| ||||||
6 | monitoring Schedules II, III, IV, and V controlled substances | ||||||
7 | that are dispensed
within the State by a practitioner or | ||||||
8 | pharmacist or dispensed to an
address within the State by a | ||||||
9 | pharmacy that has obtained a license,
permit, or other | ||||||
10 | authorization to operate from the Department of Financial and | ||||||
11 | Professional Regulation. | ||||||
12 | (b) A practitioner or a pharmacist shall not have to pay a | ||||||
13 | fee or tax specifically
dedicated to the operation of the | ||||||
14 | system. | ||||||
15 | (c) Every dispenser within the State or any other dispenser | ||||||
16 | who has obtained
a license, permit, or other authorization to | ||||||
17 | operate from the Department of Financial and Professional | ||||||
18 | Regulation shall report to the Department the data
required by | ||||||
19 | this Section in a timely manner as prescribed by the Department | ||||||
20 | except that
reporting shall not be required for:
(1) a drug | ||||||
21 | administered directly to a patient; or
(2) a drug dispensed by | ||||||
22 | a practitioner at a facility licensed by the Department
| ||||||
23 | provided that the quantity dispensed is limited to an amount | ||||||
24 | adequate to treat
the patient for a maximum of 48 hours. | ||||||
25 | (d) Data for each controlled substance that is dispensed |
| |||||||
| |||||||
1 | shall include but not be limited
to the following:
(1) patient | ||||||
2 | identifier;
(2) drug dispensed;
(3) date of dispensing;
(4) | ||||||
3 | quantity dispensed;
(5) prescriber; and
(6) dispenser. | ||||||
4 | (e) The data shall be provided in the electronic format | ||||||
5 | specified by the Department unless a waiver has been granted by | ||||||
6 | the Department to an
individual dispenser. The Department shall | ||||||
7 | establish acceptable error tolerance rates for
data. | ||||||
8 | Dispensers shall ensure that reports fall within these | ||||||
9 | tolerances. Incomplete or
inaccurate data shall be corrected | ||||||
10 | upon notification by the Department if the dispenser
exceeds | ||||||
11 | these error tolerance rates. | ||||||
12 | (f) The Department shall be authorized to provide data to:
| ||||||
13 | (1) a designated representative of the Department of Financial | ||||||
14 | and Professional Regulation who
is involved in a bona fide | ||||||
15 | specific investigation involving a designated person;
(2) an | ||||||
16 | Illinois peace officer, a
certified or full-time peace officer | ||||||
17 | of another state, or a federal peace officer
whose duty is to | ||||||
18 | enforce the laws of this State, of another state, or
of the | ||||||
19 | United States relating to drugs and who is engaged in a bona | ||||||
20 | fide
specific investigation involving a designated person;
(3) | ||||||
21 | a state-operated Medicaid program;
(4) a properly convened | ||||||
22 | grand jury pursuant to a subpoena properly issued for the
| ||||||
23 | records;
(5) a practitioner or pharmacist who requests | ||||||
24 | information and certifies that the
requested information is for | ||||||
25 | the purpose of providing medical or
pharmaceutical treatment to | ||||||
26 | a bona fide current patient;
(6) in addition to the purposes |
| |||||||
| |||||||
1 | authorized under paragraph (1) of this subsection,
the | ||||||
2 | Department of Financial and Professional Regulation, for any | ||||||
3 | physician who is:
(i) associated in a partnership or other | ||||||
4 | business entity with a physician who
is already under | ||||||
5 | investigation by the Department of Financial and Professional | ||||||
6 | Regulation for
improper prescribing practices;
(ii) in a | ||||||
7 | designated geographic area for which a trend report indicates a
| ||||||
8 | substantial likelihood that inappropriate prescribing may be | ||||||
9 | occurring;
or
(iii) in a designated geographic area for which a | ||||||
10 | report on another physician
in that area indicates a | ||||||
11 | substantial likelihood that inappropriate
prescribing may be | ||||||
12 | occurring in that area;
(7) in addition to the purposes | ||||||
13 | authorized under paragraph (1) of this subsection,
the | ||||||
14 | Department of Financial and Professional Regulation, for any | ||||||
15 | advanced practice nurse who is:
(i) associated in a partnership | ||||||
16 | or other business entity with a physician who
is already under | ||||||
17 | investigation by the Department of Financial and Professional | ||||||
18 | Regulation for improper prescribing practices;
(ii) associated | ||||||
19 | in a partnership or other business entity with an advanced
| ||||||
20 | practice nurse practitioner who is already under investigation | ||||||
21 | by the
Department of Financial and Professional Regulation for | ||||||
22 | improper prescribing practices;
(iii) in a designated | ||||||
23 | geographic area for which a trend report indicates a
| ||||||
24 | substantial likelihood that inappropriate prescribing may be | ||||||
25 | occurring;
or
(iv) in a designated geographic area for which a | ||||||
26 | report on a physician or
another advanced practice nurse |
| |||||||
| |||||||
1 | practitioner in that area indicates a
substantial likelihood | ||||||
2 | that inappropriate prescribing may be occurring in
that area; | ||||||
3 | or
(8) a judge or a probation officer or parole agent | ||||||
4 | administering a diversion or probation
program of a criminal | ||||||
5 | defendant arising out of a violation of this Act or of
a | ||||||
6 | criminal defendant who is documented by the court as a | ||||||
7 | substance abuser
who is eligible to participate in a | ||||||
8 | court-ordered drug diversion or probation
program. | ||||||
9 | (g) The Department of Healthcare and Family Services may | ||||||
10 | use any data or reports from the system
for the purpose of | ||||||
11 | identifying Medicaid recipients whose usage of controlled
| ||||||
12 | substances may be appropriately managed by a single outpatient | ||||||
13 | pharmacy or
primary care physician. | ||||||
14 | (h) A person who receives data or any report of the system | ||||||
15 | from the Department shall not
provide it to any other person or | ||||||
16 | entity except by order of a court of competent
jurisdiction, | ||||||
17 | except that:
(1) a peace officer specified in paragraph (f)(2) | ||||||
18 | of this Section who is authorized
to receive data or a report | ||||||
19 | may share that information with other peace officers
specified | ||||||
20 | in paragraph (f)(2) of this Section authorized to receive data | ||||||
21 | or a
report if the peace officers specified in paragraph (f)(2) | ||||||
22 | of this Section are
working on a bona fide specific | ||||||
23 | investigation involving a designated person.
Both the person | ||||||
24 | providing and the person receiving the data or report under
| ||||||
25 | this subsection shall document in writing each person to whom | ||||||
26 | the data or
report has been given or received and the day, |
| |||||||
| |||||||
1 | month, and year that the data or
report has been given or | ||||||
2 | received. This document shall be maintained in a file
by each | ||||||
3 | law enforcement agency engaged in the investigation; and
(2) a | ||||||
4 | representative of the Department of Healthcare and Family | ||||||
5 | Services may share data or
reports regarding overutilization by | ||||||
6 | Medicaid recipients with the Department of Financial and | ||||||
7 | Professional Regulation or with a law enforcement
officer | ||||||
8 | designated in paragraph (f)(2) of this Section; and
(3) the | ||||||
9 | Department of Healthcare and Family Services may submit the | ||||||
10 | data as evidence in an
administrative hearing held in | ||||||
11 | accordance with the Illinois Administrative Procedure Act. | ||||||
12 | (i) The Department, all peace officers specified in
| ||||||
13 | paragraph (f)(2) of this Section, all officers of the court, | ||||||
14 | and all regulatory agencies
and officers, in using the data for | ||||||
15 | investigative or prosecution purposes, shall
consider the | ||||||
16 | nature of the prescriber's and dispenser's practice and the | ||||||
17 | condition for
which the patient is being treated. | ||||||
18 | (j) The data and any report obtained therefrom shall not be | ||||||
19 | a public record, except that
the Department of Healthcare and | ||||||
20 | Family Services may submit the data as evidence in an
| ||||||
21 | administrative hearing held in accordance with the Illinois | ||||||
22 | Administrative Procedure Act. | ||||||
23 | (k) Knowing failure by a dispenser to transmit data to the | ||||||
24 | Department as required by
subsection (c), (d), or (e) of this | ||||||
25 | Section is a Class A misdemeanor. | ||||||
26 | (l) Knowing disclosure of transmitted data to a person not |
| |||||||
| |||||||
1 | authorized by subsections (f)
to (h) of this Section or | ||||||
2 | authorized by the Pharmacy Practice Act of 1987, or obtaining
| ||||||
3 | information under this Section not relating to a bona fide | ||||||
4 | specific investigation, is a Class 4 felony. | ||||||
5 | (m) The Department shall submit an application to the | ||||||
6 | United States
Department of Justice for a drug diversion grant | ||||||
7 | to fund a pilot project to study a
real-time electronic | ||||||
8 | monitoring system for Schedules II, III, IV, and V controlled
| ||||||
9 | substances. The pilot project shall:
(1) be conducted in 2 | ||||||
10 | rural counties that have an interactive real-time
electronic | ||||||
11 | information system in place for monitoring patient utilization | ||||||
12 | of
health and social services through a federally funded | ||||||
13 | community access
program; and
(2) study the use of an | ||||||
14 | interactive system that includes a relational data base with
| ||||||
15 | query capability. | ||||||
16 | (n) Provisions in this Section that relate to data | ||||||
17 | collection, disclosure, access, and
penalties shall apply to | ||||||
18 | the pilot project authorized under subsection (m) of this
| ||||||
19 | Section. | ||||||
20 | (o) The Department may limit the length of time that data
| ||||||
21 | remain in the electronic system. Any data removed from the | ||||||
22 | system shall be
archived and subject to retrieval within a | ||||||
23 | reasonable time after a request from a
person authorized to | ||||||
24 | review data under this Section. | ||||||
25 | (p)(1) The Department shall work with the Department of | ||||||
26 | Financial and Professional Regulation for the development of a |
| |||||||
| |||||||
1 | continuing education
program about the purposes and uses of the | ||||||
2 | electronic system for monitoring
established in this Section. | ||||||
3 | (2) The Attorney General shall work with the Illinois State | ||||||
4 | Bar Association for the
development of a continuing education | ||||||
5 | program for attorneys about the
purposes and uses of the | ||||||
6 | electronic system for monitoring established in this
Section. | ||||||
7 | (3) The Department shall work with the Illinois Law | ||||||
8 | Enforcement Training Standards Board for the development of a
| ||||||
9 | continuing education program for law enforcement officers | ||||||
10 | about the purposes
and users of the electronic system for | ||||||
11 | monitoring established in this Section.
| ||||||
12 | (720 ILCS 570/406) (from Ch. 56 1/2, par. 1406)
| ||||||
13 | Sec. 406. (a) It is unlawful for any person:
| ||||||
14 | (1) who is subject to Article III knowingly to | ||||||
15 | distribute or dispense
a controlled substance in violation | ||||||
16 | of Sections 308 through 314 of this Act; or
| ||||||
17 | (2) who is a registrant, to manufacture a controlled | ||||||
18 | substance not
authorized by his registration, or to | ||||||
19 | distribute or dispense a controlled
substance not | ||||||
20 | authorized by his registration to another registrant or | ||||||
21 | other
authorized person; or
| ||||||
22 | (3) to refuse or fail to make, keep or furnish any | ||||||
23 | record, notification,
order form, statement, invoice or | ||||||
24 | information required under this Act; or
| ||||||
25 | (4) to refuse an entry into any premises for any |
| |||||||
| |||||||
1 | inspection authorized by
this Act; or
| ||||||
2 | (5) knowingly to keep or maintain any store, shop, | ||||||
3 | warehouse, dwelling,
building, vehicle, boat, aircraft, or | ||||||
4 | other structure or place, which is
resorted to by a person | ||||||
5 | unlawfully possessing controlled substances, or
which is | ||||||
6 | used for possessing, manufacturing, dispensing or | ||||||
7 | distributing
controlled substances in violation of this | ||||||
8 | Act.
| ||||||
9 | Any person who violates this subsection (a) is guilty of a | ||||||
10 | Class A
misdemeanor for the first offense and a Class 4 felony | ||||||
11 | for each subsequent
offense. The fine for each subsequent | ||||||
12 | offense shall not be more than
$100,000. In addition, any | ||||||
13 | practitioner who is found guilty of violating
this subsection | ||||||
14 | (a) is subject to suspension and revocation of his
professional | ||||||
15 | license, in accordance with such procedures as are provided by
| ||||||
16 | law for the taking of disciplinary action with regard to the | ||||||
17 | license of
said practitioner's profession.
| ||||||
18 | (b) It is unlawful for any person knowingly:
| ||||||
19 | (1) to distribute, as a registrant, a controlled | ||||||
20 | substance classified
in Schedule I or II, except pursuant | ||||||
21 | to an order form as required by Section
307 of this Act; or
| ||||||
22 | (2) to use, in the course of the manufacture or | ||||||
23 | distribution of a
controlled
substance, a registration | ||||||
24 | number which is fictitious, revoked, suspended,
or issued | ||||||
25 | to another person; or
| ||||||
26 | (3) to acquire or obtain possession of a controlled |
| |||||||
| |||||||
1 | substance by
misrepresentation, fraud, forgery, deception | ||||||
2 | or subterfuge; or
| ||||||
3 | (4) to furnish false or fraudulent material | ||||||
4 | information in, or omit any
material information from, any | ||||||
5 | application, report or other document required
to be kept | ||||||
6 | or filed under this Act, or any record required to be kept | ||||||
7 | by
this Act; or
| ||||||
8 | (5) to make, distribute or possess any punch, die, | ||||||
9 | plate, stone or other
thing designed to print, imprint or | ||||||
10 | reproduce the trademark, trade name
or other identifying | ||||||
11 | mark, imprint or device of another, or any likeness
of any | ||||||
12 | of the foregoing, upon any controlled substance or | ||||||
13 | container or labeling
thereof so as to render the drug a | ||||||
14 | counterfeit substance; or
| ||||||
15 | (6) to possess without authorization, blank | ||||||
16 | prescription forms
or counterfeit prescription forms; or
| ||||||
17 | (7) (Blank).
| ||||||
18 | Any person who violates this subsection (b) is guilty of a | ||||||
19 | Class 4 felony
for the first offense and a Class 3 felony for | ||||||
20 | each subsequent offense.
The fine for the first offense shall | ||||||
21 | be not more than $100,000. The fine
for each subsequent offense | ||||||
22 | shall not be more than $200,000.
| ||||||
23 | (c) (Blank)
A person who knowingly or intentionally | ||||||
24 | violates Section 316, 317, 318,
or 319 is guilty of a Class A | ||||||
25 | misdemeanor .
| ||||||
26 | (Source: P.A. 91-576, eff. 4-1-00.)
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 | (720 ILCS 570/316 rep.)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | (720 ILCS 570/317 rep.) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | (720 ILCS 570/318 rep.) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | (720 ILCS 570/319 rep.) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | (720 ILCS 570/320 rep.) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Section 10. The Illinois Controlled Substances Act is | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | amended by repealing Sections 316, 317, 318, 319, and 320.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Section 99. Effective date. This Act takes effect January | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | 1, 2008.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||